Human interventional
IV vitamin C
A 350-patient study reported improvement in several treatment-related symptom scores over four weeks. View study.
Research Library · Integrative Oncology
Breast Cancer Natural Treatments: Research and Studies
This library separates human trials, observational findings and laboratory research so patients can see what was studied, in whom, and which outcome actually changed.
Answer first: This library separates human trials, observational findings and laboratory research so patients can see what was studied, in whom, and which outcome actually changed.
Cancer Consultation
Speak With Our Cancer Patient Care Team
Tell us where you are in your cancer journey. Our Patient Care Team can answer questions and help determine the next step.
*
Required fields
Prefer to speak with someone now?
1-800-923-7878
✓
Stage 4 & advanced cancer patients welcome
✓
Out-of-state & international patients welcome
✓
Questions before scheduling are welcome
How to read this library
Evidence level and outcome are not the same thing.
Human randomized trialHuman observational studySystematic reviewCase reportLaboratory researchAnimal research
Each entry identifies whether the outcome was tumor response, recurrence, survival, symptoms, treatment tolerance, quality of life or a laboratory marker.
Human breast-cancer studies
Selected research with direct source links.
Randomized trial
Mistletoe
Trials have investigated quality of life during chemotherapy; these outcomes are different from proof of tumor control. View study.
Randomized trials
Curcumin
A small radiation-dermatitis trial was positive, while a larger 686-patient trial did not show a significant overall benefit. View larger study.
Randomized trial
Acupuncture
A multicenter trial found a statistically significant reduction in aromatase-inhibitor joint pain, with the clinical magnitude interpreted cautiously. View study.
Randomized trial
Exercise
Supervised aerobic and resistance exercise during chemotherapy supported quality of life, fatigue and functional capacity. View study.
Randomized trial
Mindfulness and yoga
Breast-cancer trials have examined fatigue, mood, quality of life and inflammatory markers. View yoga study.
Compounds under active investigation
Mechanistic interest does not automatically equal a patient outcome.
Polyphenol
Resveratrol
Research examines signaling, metabolism, oxidative stress and tumor biology; much of the breast-cancer evidence is preclinical.
Botanical
Silymarin
Silymarin research includes liver support questions and laboratory investigation of cancer-related pathways.
Green tea
EGCG
EGCG is studied for signaling, proliferation and metabolism; formulation and achieved human exposure matter when interpreting results.
Redox support
Glutathione
Glutathione biology is complex in oncology and must be separated into questions about normal-tissue support, drug exposure and tumor redox adaptation.
Oxidative therapy
Ozone
Clinical cancer evidence remains limited; claims should be distinguished from mechanistic or non-breast-cancer research.
Emerging gas therapy
Molecular hydrogen
Small human studies in other cancers have examined feasibility and supportive outcomes; breast-cancer-specific trials are still needed.
Research standards
How Sunridge keeps the library useful.
- Direct link to the primary paper or authoritative review.
- Study population and breast-cancer subtype when reported.
- Number of participants and study design.
- Outcome actually measured.
- Evidence label and last-reviewed date.
- No conversion of laboratory findings into claims of proven clinical benefit.
A closer look
How this topic fits the complete breast-cancer plan.
Reading an integrative oncology paper begins with the population. A study in breast-cancer survivors is not automatically evidence for people receiving active chemotherapy, and research in another cancer does not become breast-cancer evidence simply because the mechanism is interesting. Next examine the comparison group, sample size, duration and outcome. Improvement in fatigue, dermatitis or a laboratory marker is valuable, but it is not the same as tumor shrinkage or longer survival.
The library therefore uses direct study links and plain-language labels. Positive, negative and mixed results all belong in the record. Sunridge can then discuss how a finding might inform an individualized supportive plan, what remains uncertain, and whether the therapy’s formulation and delivery resemble what was actually studied. Entries are reviewed as new human research becomes available.
Prepare for a Sunridge review
The right records make the first conversation more useful.
Before contacting the Patient Care Team, gather the exact therapy, formulation, dose or delivery method of interest and the outcome the patient hopes to improve. A concise one-page chronology is often helpful: diagnosis date, stage, major test results, treatments received, response, side effects and the questions that matter most now.
Step 1
Send the records
The team can explain which reports and images are needed before a physician review.
Step 2
Define the priorities
List the treatment, symptom, recovery and quality-of-life questions you want the consultation to address.
Step 3
Plan the visit
Out-of-state and international patients can discuss timing, Scottsdale travel and which services require an in-person appointment.
Continue exploring
Explore Sunridge integrative therapies
Learn how these physician-directed therapies are evaluated within a personalized cancer-care program.
A personalized next step
Bring the complete breast-cancer story to the conversation.
Our Patient Care Team can explain which records to send, how a physician review works and what to expect when traveling to Scottsdale.
Request a consultationCall 1-800-923-7878This page is educational and does not provide a diagnosis or individualized treatment recommendation. Medication and integrative-treatment decisions require review of the complete case by qualified clinicians. Content reviewed August 2026.